Clinical Trial Update: To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing INS068 with insulin glargine in adults with type 2 diabetes on basal insulin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• INS068
• Lantus (insulin glargine)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED